Listen "Onconova Therapeutics (NASDAQ: ONTX) CEO Interview Series"
Episode Synopsis
Onconova Therapeutics (NASDAQ: ONTX) CEO: Steve Fruchtman THIS INTERVIEW HAS EXPIRED
More episodes of the podcast The Wall Street Analyzer
Token Community (OTC: TKCM)
12/04/2023